Ray Dalio's AXSM Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 47,444 shares of Axsome Therapeutics, Inc. (AXSM) worth $8.67 M, representing 0.03% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, Ray Dalio has maintained this position in AXSM for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 64,467 shares. Largest reduction occurred in Q3 2025, reducing 107,292 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Axsome Therapeutics (AXSM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Axsome Therapeutics (AXSM) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +47,444 | New Buy | 47,444 | $182.64 |
| Q3 2025 | -107,292 | Sold Out | 0 | $0.00 |
| Q2 2025 | +64,467 | Add 150.54% | 107,292 | $104.39 |
| Q1 2025 | +42,825 | New Buy | 42,825 | $116.63 |
Ray Dalio's Axsome Therapeutics Investment FAQs
Ray Dalio first purchased Axsome Therapeutics, Inc. (AXSM) in Q1 2025, acquiring 42,825 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Axsome Therapeutics, Inc. (AXSM) for 4 quarters since Q1 2025.
Ray Dalio's largest addition to Axsome Therapeutics, Inc. (AXSM) was in Q2 2025, adding 107,292 shares worth $11.2 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 47,444 shares of Axsome Therapeutics, Inc. (AXSM), valued at approximately $8.67 M.
As of the Q4 2025 filing, Axsome Therapeutics, Inc. (AXSM) represents approximately 0.03% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Axsome Therapeutics, Inc. (AXSM) was 107,292 shares, as reported at the end of Q2 2025.